405 related articles for article (PubMed ID: 32828126)
21. Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer.
Du H; Li Y; Pang S; Enofe I; Pallante P; Zhu L; Hang J; Chen L
J Thorac Dis; 2023 Nov; 15(11):6178-6191. PubMed ID: 38090289
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
Guo T; Hou D; Yu D
Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
[TBL] [Abstract][Full Text] [Related]
23. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
25. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of colorectal cancer: A five-gene prognostic signature based on RNA-binding proteins.
Liang Q; Du X; Mao L; Wang G
Saudi J Gastroenterol; 2021; 27(4):223-233. PubMed ID: 34169901
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
29. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
[TBL] [Abstract][Full Text] [Related]
32. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
34. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
[TBL] [Abstract][Full Text] [Related]
35. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
Peng C; Ma W; Xia W; Zheng W
Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
[TBL] [Abstract][Full Text] [Related]
36. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
Liu H; Ye H
Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
[TBL] [Abstract][Full Text] [Related]
37. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
Wu Z; Wang YM; Dai Y; Chen LA
Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of intestinal microbiota and host gene expression in colorectal cancer patients.
Chen Y; Si H; Bao B; Li S; Teng D; Yan Y; Hu S; Xu Y; Du X
J Med Microbiol; 2022 Sep; 71(9):. PubMed ID: 36136380
[No Abstract] [Full Text] [Related]
39. Identification of hub genes and pathways in lung metastatic colorectal cancer.
Dai W; Guo C; Wang Y; Li Y; Xie R; Wu J; Yao B; Xie D; He L; Li Y; Huang H; Wang Y; Liu S
BMC Cancer; 2023 Apr; 23(1):323. PubMed ID: 37024866
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
Chen J; Wang Z; Shen X; Cui X; Guo Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
